On December 11th, 2023, Keran Pharmaceuticals moved to a new house in No. 88 Shangke Road, Pudong, Shanghai. With more complete laboratory space and more comfortable office environment, Keran Pharma has started a new chapter with a brand new outlook.

Recently, Cholesgen (Shanghai) Co. Ltd. has completed its Series A financing of over RMB 100 million, which was led by Gaorong Ventures, with participation from Great Filter Venture, Leading Capital, and AstraZeneca-CICC Capital, as well as investment from angel investors, Trinity Fund. The company will utilize the financing to accelerate the development of its core innovative drug pipeline, expand its R&D team, and expand external collaborations and office space.